Integer Holdings Corp (ITGR) valuation
Integer Holdings P/E ratio history
Integer Holdings trades at 42.2 times its earnings over the last twelve months and 18.9 times the earnings analysts expect over the next twelve. At its last 8 fiscal year ends its P/E ranged from 27.1 (year to Dec 2025) to 163.6 (year to Dec 2016), with a median of 34.6.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Dec 31, 2025 | $78.43 | $2.89 | 27.1 | 12.4 |
| Dec 31, 2024 | $132.52 | $3.36 | 39.4 | 22.6 |
| Dec 31, 2023 | $99.08 | $2.69 | 36.8 | — |
| Dec 31, 2022 | $68.46 | $1.99 | 34.4 | — |
| Dec 31, 2021 | $85.59 | $2.91 | 29.4 | — |
| Dec 31, 2020 | $81.19 | $2.34 | 34.7 | — |
| Dec 31, 2019 | $80.43 | $2.75 | 29.3 | — |
| Dec 28, 2018 | $76.03 | — | n/m | — |
| Dec 29, 2017 | $45.30 | — | n/m | — |
| Dec 30, 2016 | $29.45 | $0.18 | 163.6 | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Integer Holdings valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| Integer HoldingsITGR | $4.30B | 42.2 | 18.9 | 2.4 |
| Livanova PlcLIVN | $4.34B | 23.3 | 17.5 | 3.0 |
| Adaptive BiotechnologiesADPT | $4.26B | — | — | 13.8 |
| Edgewise TherapeuticsEWTX | $4.18B | — | — | — |
| Indivior PharmaceuticalsINDV | $4.17B | 9.9 | 7.9 | 3.0 |
| CorvelCRVL | $4.17B | 36.5 | — | 4.2 |
| ErascaERAS | $4.46B | — | — | — |
| Dianthus TherapeuticsDNTH | $4.50B | — | — | — |
| CaredxCDNA | $4.52B | 36.6 | 69.0 | 9.1 |
| Peer median | 29.9 | 17.5 | 4.2 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: ITGR financials · ITGR returns
No forecast, no recommendation. This page describes Integer Holdings Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.